The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntegraFin Holdings Regulatory News (IHP)

Share Price Information for IntegraFin Holdings (IHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 306.00
Ask: 306.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.163%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 306.00
IHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Placing of IntegraFin Shares

30 Sep 2019 16:46

RNS Number : 2156O
Peel Hunt LLP
30 September 2019
 

NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA.

 

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

 

THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY, NOR SHALL THERE BE ANY SALE, OF THE SECURITIES REFERRED TO HEREIN IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.

 

PRESS RELEASE

 

United Kingdom, 30 September 2019

 

Accelerated bookbuilt offering of approximately 6 million existing ordinary shares in IntegraFin Holdings plc

 

Michael Howard (the "Vendor") is selling approximately 6 million existing ordinary shares of IntegraFin Holdings plc ("IntegraFin" or the "Company") corresponding to approximately 1.8% of the outstanding ordinary share capital of the Company. The sale will be undertaken via an accelerated bookbuilt offering to institutional investors (the "Offering").

 

The Offering is being undertaken, primarily, to enable Michael Howard to provide seed funding for a charitable foundation and, residually, for diversification purposes. Michael Howard continues to be a director of the Company and his working relationship with the group is unchanged. IntegraFin will not receive any proceeds from the Offering.

 

Barclays Bank PLC ("Barclays") and Peel Hunt LLP ("Peel Hunt") are acting as Joint Global Coordinators and Bookrunners for the Offering and Evercore Partners International LLP ("Evercore") is acting as Financial Adviser to the Vendor. Bookbuilding will commence immediately. The right is reserved to close the books at any time. The sale price of the shares and the final size of the Offering will be determined after the books have closed.

 

Following completion of the Offering, the Vendor will own approximately 11.5% of the outstanding ordinary share capital of the Company. This residual shareholding will be subject to a 90 day lock-up undertaking.

 

 

Enquiries:

 

Barclays +44 (0)20 7623 2323

Chris Madderson

Lawrence Jamieson

 

Peel Hunt +44 (0)20 7418 8900

Jock Maxwell Macdonald

Sohail Akbar

 

Evercore +44 (0)20 7653 6000

Jim Renwick

Lucy Berryman

 

Disclaimer

 

THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN, AND WILL NOT BE, REGISTRED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN APPLICABLE EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT. THERE IS NO INTENTION TO REGISTER ANY SECURITIES REFERRED TO HEREIN IN THE UNITED STATES OR TO CONDUCT A PUBLIC OFFERING OF SECURITIES IN THE UNITED STATES. ANY SECURITIES SOLD IN THE UNITED STATES WILL BE SOLD ONLY TO QUALIFIED INSTITUTIONAL BUYERS (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT).

 

WITH RESPECT TO THE MEMBER STATES OF THE EUROPEAN ECONOMIC AREA WHICH HAVE IMPLEMENTED DIRECTIVE 2003/71/EC AS AMENDED (TOGETHER WITH ANY APPLICABLE IMPLEMENTING MEASURES IN ANY MEMBER STATE, THE "PROSPECTUS DIRECTIVE") (EACH A "RELEVANT MEMBER STATE"), NO ACTION HAS BEEN UNDERTAKEN OR WILL BE UNDERTAKEN TO MAKE AN OFFER TO THE PUBLIC OF THE SECURITIES REFERRED TO HEREIN REQUIRING A PUBLICATION OF A PROSPECTUS IN ANY RELEVANT MEMBER STATE. AS A RESULT, THESE SECURITIES MAY ONLY BE OFFERED OR SOLD IN ANY RELEVANT MEMBER STATE PURSUANT TO AN EXEMPTION UNDER THE PROSPECTUS DIRECTIVE.

 

THIS ANNOUNCEMENT IS ONLY ADDRESSED TO, AND DIRECTED AT, PERSONS IN MEMBER STATES OF THE EUROPEAN ECONOMIC AREA WHO ARE "QUALIFIED INVESTORS" WITHIN THE MEANING OF ARTICLE 2(1)E OF THE PROSPECTUS DIRECTIVE ("QUALIFIED INVESTORS").

 

IN THE UNITED KINGDOM, THIS ANNOUNCEMENT IS DIRECTED ONLY AT, QUALIFIED INVESTORS WHO ARE (I) PERSONS HAVING PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS WHO FALL WITHIN THE DEFINITION OF "INVESTMENT PROFESSIONALS" IN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (THE "ORDER"), OR (II) HIGH NET WORTH ENTITIES FALLING WITHIN ARTICLE 49(2) OF THE ORDER, OR (III) OTHER PERSONS TO WHOM IT MAY LAWFULLY BE COMMUNICATED ("RELEVANT PERSONS"). UNDER NO CIRCUMSTANCES SHOULD PERSONS WHO ARE NOT RELEVANT PERSONS RELY OR ACT UPON THE CONTENTS OF THIS ANNOUNCEMENT. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IN THE UNITED KINGDOM IS AVAILABLE ONLY TO, AND WILL BE ENGAGED ONLY WITH, RELEVANT PERSONS.

 

BARCLAYS IS IN THE UK AUTHORISED BY THE PRUDENTIAL REGULATORY AUTHORITY AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY AND THE PRUDENTIAL REGULATORY AUTHORITY. PEEL HUNT AND EVERCORE ARE IN THE UK IS REGULATED BY THE FINANCIAL CONDUCT AUTHORITY. BARCLAYS, PEEL HUNT AND EVERCORE ARE ACTING FOR THE VENDOR AND FOR NO-ONE ELSE IN CONNECTION WITH THE TRANSACTION AND WILL NOT BE RESPONSIBLE TO ANYONE OTHER THAN THE VENDOR FOR PROVIDING THE PROTECTIONS AFFORDED TO CUSTOMERS OF BARCLAYS OR PEEL HUNT OR FOR AFFORDING ADVICE IN RELATION TO THE TRANSACTION, THE CONTENTS OF THIS ANNOUNCEMENT OR ANY TRANSACTION, ARRANGEMENT OR OTHER MATTER REFERRED TO IN THIS ANNOUNCEMENT. BARCLAYS AND PEEL HUNT MAY PARTICIPATE IN THE TRANSACTION ON A PROPRIETARY BASIS.

 

THIS ANNOUNCEMENT HAS BEEN ISSUED BY PEEL HUNT ON BEHALF OF THE VENDOR AND IS THE SOLE RESPONSIBILITY OF THE VENDOR APART FROM THE RESPONSIBILITIES AND LIABILITIES, IF ANY, THAT MAY BE IMPOSED ON BARCLAYS, PEEL HUNT OR EVERCORE BY THE FINANCIAL SERVICES AND MARKETS ACT 2000, NONE OF BARCLAYS, PEEL HUNT OR EVERCORE ACCEPTS ANY RESPONSIBILITY WHATSOEVER AND MAKES NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, FOR THE CONTENTS OF THIS ANNOUNCEMENT, INCLUDING ITS ACCURACY, COMPLETENESS OR VERIFICATION OR FOR ANY OTHER STATEMENT MADE OR PURPORTED TO BE MADE BY THE VENDOR, OR ON THE VENDOR'S BEHALF OR ON BARCLAYS', PEEL HUNT'S OR EVERCORE'S BEHALF, IN CONNECTION WITH THE VENDOR OR THE TRANSACTION, AND NOTHING IN THIS ANNOUNCEMENT IS OR SHALL BE RELIED UPON AS A PROMISE OR REPRESENTATION IN THIS RESPECT, WHETHER AS TO THE PAST OR FUTURE PERFORMANCE. EACH OF BARCLAYS, PEEL HUNT AND EVERCORE ACCORDINGLY DISCLAIMS TO THE FULLEST EXTENT PERMITTED BY LAW ALL AND ANY RESPONSIBILITY AND LIABILITY, WHETHER ARISING IN TORT, CONTRACT OR OTHERWISE, WHICH IT MIGHT OTHERWISE HAVE IN RESPECT OF THIS DOCUMENT AND ANY SUCH STATEMENT.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEUROVRKNAKOAR
Date   Source Headline
20th Jan 20212:00 pmRNSNotice of AGM
19th Jan 20217:00 amRNS1st Quarter Results
15th Jan 20211:47 pmRNSDirector/PDMR Shareholding
13th Jan 20214:08 pmRNSHolding(s) in Company
11th Jan 20212:34 pmRNSHolding(s) in Company
11th Jan 202111:30 amRNSAcquisition
5th Jan 20216:28 pmRNSListing Rule 9.6.14(R) Disclosure
4th Jan 20214:45 pmRNSNo intention to make an offer for Nucleus
23rd Dec 20201:42 pmRNSDirector/PDMR Shareholding
17th Dec 202010:00 amRNSHolding(s) in Company
17th Dec 20207:00 amRNSFinal Results
2nd Dec 20205:35 pmRNSStatement re Nucleus Financial Group plc
25th Nov 20207:00 amRNSAppointment of Joint Corporate Broker
24th Nov 20204:48 pmRNSDirector/PDMR Shareholding
5th Nov 202011:37 amRNSHolding(s) in Company
23rd Oct 20203:29 pmRNSDirector/PDMR Shareholding
20th Oct 20207:00 amRNSQ4 Funds Under Direction Update
30th Sep 202011:04 amRNSResult of General Meeting
28th Sep 20204:21 pmRNSHolding(s) in Company
25th Sep 202010:52 amRNSHolding(s) in Company
23rd Sep 20204:54 pmRNSHolding(s) in Company
23rd Sep 20204:22 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
15th Sep 20203:35 pmRNSDirector/PDMR Shareholding
9th Sep 20207:00 amRNSNotice of GM
7th Sep 202012:30 pmRNSDirector/PDMR Shareholding
1st Sep 20201:00 pmRNSDirectorate Change
24th Aug 20203:13 pmRNSDirector/PDMR Shareholding
5th Aug 20204:54 pmRNSDirector/PDMR Shareholding
4th Aug 20201:43 pmRNSHolding(s) in Company
3rd Aug 20209:45 amRNSHolding(s) in Company
27th Jul 202011:40 amRNSDirector/PDMR Shareholding
24th Jul 20203:16 pmRNSHolding(s) in Company
22nd Jul 20202:01 pmRNSDirector/PDMR Shareholding
22nd Jul 202012:00 pmRNSHolding(s) in Company
21st Jul 20207:00 amRNSQ3 Funds Under Direction Update
14th Jul 20202:30 pmRNSHolding(s) in Company
29th Jun 20203:10 pmRNSDirector/PDMR Shareholding
25th Jun 202010:27 amRNSDirector/PDMR Shareholding
24th Jun 202010:21 amRNSDirector/PDMR Shareholding
1st Jun 20201:35 pmRNSDirector/PDMR Shareholding
22nd May 20204:11 pmRNSHolding(s) in Company
22nd May 20202:11 pmRNSDirector/PDMR Shareholding
21st May 20207:00 amRNSHalf-year Report
19th May 20209:38 amRNSHolding(s) in Company
22nd Apr 20204:13 pmRNSDirector/PDMR Shareholding
21st Apr 20207:00 amRNSQ2 Funds Under Direction Update
27th Mar 20205:11 pmRNSDirector/PDMR Shareholding
26th Mar 20201:36 pmRNSHolding(s) in Company
25th Mar 202011:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.